RDY Dr. Reddy's Laboratories Limited
Healthcare$13.75+1.10%ClosedMarket Cap: $11.45B
As of 2026-05-26
Valuation
P/E (TTM)
17.55
PEG
0.04
P/B
2.94
P/S
3.30
EV/EBITDA
15.77
DCF Value
$17.51
FCF Yield
2.1%
Div Yield
0.6%
Margins & Returns
Gross Margin
52.8%
Operating Margin
14.8%
Net Margin
12.8%
ROE
11.8%
ROA
7.4%
ROIC
8.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $76.33B | 44.8% | $473.3M | $2.24B | $— | — |
| FY null | $353.47B | 52.8% | $48.87B | $45.09B | $— | $0.09 |
| Q3 null | $87.27B | 53.6% | $14.24B | $12.10B | $— | — |
| Q2 null | $88.05B | 54.7% | $17.51B | $14.37B | $— | $0.09 |
| Q1 null | $85.45B | 56.9% | $17.48B | $14.18B | $— | — |
| Q4 null | $85.06B | 55.6% | $17.65B | $15.94B | $— | — |
| FY null | $325.54B | 58.5% | $71.84B | $56.54B | $— | $0.48 |
| Q3 null | $83.59B | 58.7% | $18.72B | $14.13B | $— | — |
| Q2 null | $80.16B | 59.6% | $17.55B | $12.55B | $— | $0.48 |
| Q1 null | $76.73B | 60.4% | $17.93B | $13.92B | $— | — |
| Q4 null | $70.83B | 58.6% | $14.96B | $13.07B | $— | — |
| FY null | $279.16B | 58.6% | $67.73B | $55.68B | $— | $0.49 |